A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

T. Y. Seiwert, J. Fayette, D. Cupissol, J. M. del Campo, P. M. Clement, R. Hitt, M. Degardin, W. Zhang, A. Blackman, E. Ehrnrooth, E. E.W. Cohen

Research output: Contribution to journal › Article › peer-review